Federal Register / Vol. 90, No. 20 / Friday, January 31, 2025 / Notices 8717 

Background 

The Commission instituted this 

review on July 1, 2024 (89 FR 54519) 

and determined on October 4, 2024, that 

it would conduct an expedited review 

(89 FR 89040, November 12, 2024). 

The Commission made this 

determination pursuant to section 

751(c) of the Act (19 U.S.C. 1675(c)). It 

completed and filed its determination in 

this review on January 27, 2025. The 

views of the Commission are contained 

in USITC Publication 5580 (January 

2025), entitled Steel Wire Garment 

Hangers from China: Investigation No. 

731–TA–1123 (Third Review). 

By order of the Commission. 

Issued: January 28, 2025. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2025–02050 Filed 1–30–25; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1413] 

Certain Wireless Front-End Modules 

and Devices Containing the Same; 

Notice of Commission Decision Not To 

Review an Initial Determination 

Granting Motion To Amend the 

Complaint and Notice of Investigation 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the U.S. International Trade 

Commission has determined not to 

review an initial determination (‘‘ID’’) 

(Order No. 17) of the presiding 

administrative law judge (‘‘ALJ’’) 

granting complainants’ motion to amend 

the complaint and notice of 

investigation to assert additional patent 

claims. 

FOR FURTHER INFORMATION CONTACT: 

Houda Morad, Office of the General 

Counsel, U.S. International Trade 

Commission, 500 E Street SW, 

Washington, DC 20436, telephone (202) 

708–4716. Copies of non-confidential 

documents filed in connection with this 

investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. General 

information concerning the Commission 

may also be obtained by accessing its 

internet server at https://www.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: On August 

22, 2024, the Commission instituted this 

investigation based on a complaint filed 

on behalf of complainants Skyworks 

Solutions, Inc. of Irvine, California; 

Skyworks Solutions Canada, Inc. of 

Ottawa, Canada; and Skyworks Global 

Pte. Ltd. of Singapore (collectively, 

‘‘Skyworks’’). 89 FR 67969–70 (Aug. 22, 

2024). The complaint, as supplemented, 

alleges violations of section 337 of the 

Tariff Act of 1930, as amended, 19 

U.S.C. 1337, based upon the importation 

into the United States, the sale for 

importation, or sale within the United 

States after importation of certain 

wireless front-end modules and devices 

containing the same by reason of the 

infringement of certain claims of U.S. 

Patent Nos. 8,717,101; 9,917,563; 

7,409,200 (‘‘the ’200 patent’’); 9,450,579 

(‘‘the ’579 patent’’); and 9,148,194. Id. 

The notice of investigation names the 

following respondents: Kangxi 

Communication Technologies 

(Shanghai) Co., Ltd. of Shanghai, China; 

Grand Chip Labs, Inc. of Tustin, 

California; D-Link Corporation of 

Taipei, Taiwan; D-Link Systems Inc. of 

Irvine, California; and Ruijie Networks 

Co., Ltd. of Fuzhou, China (collectively, 

‘‘Respondents’’). Id. The Office of Unfair 

Import Investigations (‘‘OUII’’) is also a 

party to the investigation. Id. 

On November 1, 2024, Skyworks filed 

a motion (‘‘Motion’’) to terminate the 

investigation as to the ’200 patent based 

on the withdrawal of the complaint as 

to that patent. The Motion also seeks to 

amend the complaint and notice of 

investigation to further assert dependent 

claims 2, 3, 8, and 9 of the ’579 patent 

(‘‘the added patent claims’’). The 

Motion is unopposed with respect to the 

partial termination of the investigation 

as to the ’200 patent, but is opposed 

with respect to the requested 

amendment to assert additional 

dependent claims of the ’579 patent. On 

November 13, 2024, some of the 

Respondents filed a response, in which 

other Respondents later joined on 

November 15, 2024, in opposition to 

Skyworks’ request to amend the 

complaint and notice of investigation. 

On November 13, 2024, OUII filed a 

response in support of Skyworks’ 

requested amendment. 

On November 8, 2024, the ALJ issued 

an ID (Order No. 13) granting the 

Motion with respect to the partial 

termination of the investigation as to the 

’200 patent. Order No. 13 (Nov. 8, 2024), 

unreviewed by Comm’n Notice (Dec. 10, 

2024). On December 31, 2024, the ALJ 

issued the subject ID (Order No. 17) 

granting Complainants’ motion to 

amend the complaint and notice of 

investigation pursuant to Commission 

Rule 210.14(b)(1) (19 CFR 210.14(b)(1)). 

The ID finds good cause to amend 

because ‘‘adjudicating the [added patent 

claims] in this Investigation serves the 

public interest by conserving the 

Commission’s and the Parties’ 

resources’’ and ‘‘[t]he added claims are 

related to claims already being 

litigated.’’ ID at 9. 

No petition for review of the subject 

ID was filed. 

The Commission has determined not 

to review the subject ID. The complaint 

and notice of investigation are amended 

to include the added patent claims. 

The Commission’s vote for this 

determination took place on January 27, 

2025. 

The authority for the Commission’s 

determination is contained in section 

337 of the Tariff Act of 1930, as 

amended (19 U.S.C. 1337), and in part 

210 of the Commission’s Rules of 

Practice and Procedure (19 CFR part 

210). 

By order of the Commission. 

Issued: January 28, 2025. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2025–02057 Filed 1–30–25; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Integrated Photonics 

Institute for Manufacturing Innovation 

Operating Under the Name of the 

American Institute for Manufacturing 

Integrated Photonics 

Notice is hereby given that, on 

October 14, 2024, pursuant to section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), The 

Integrated Photonics Institute for 

Manufacturing Innovation operating 

under the name of the American 

Institute for Manufacturing Integrated 

Photonics (‘‘AIM Photonics’’) has filed 

written notifications simultaneously 

with the Attorney General and the 

Federal Trade Commission disclosing 

changes in its membership. The 

notifications were filed for the purpose 

of extending the Act’s provisions 

limiting the recovery of antitrust 

plaintiffs to actual damages under 

specified circumstances. Specifically, 

Critical Frequency Design, LLC, 


ddrumheller on DSK120RN23PROD with NOTICES1
8718 Federal Register / Vol. 90, No. 20 / Friday, January 31, 2025 / Notices 

Melbourne, FL; FlexCompute Inc., 

Watertown, MA; MPI America Inc., San 

Jose, CA; Phlotonics, Inc., Rochester, 

NY; PICadvanced US LLC, Fort 

Lauderdale, FL; and Research 

Foundation on behalf of the University 

at Albany, Albany, NY, have been added 

as parties to this venture. 

Also, AAYUNA Inc., Allentown, PA; 

Trustees of Boston University, Boston, 

MA; Ebara Technologies, Inc., 

Sacramento, CA; George Washington 

University, Washington, DC; Presco 

Engineering, Woodbridge, CT; Teledyne 

Princeton Instruments, Trenton, NJ; and 

Milkshake Technology Inc., Menlo Park, 

CA, have withdrawn as parties to this 

venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and AIM 

Photonics intends to file additional 

written notifications disclosing all 

changes in membership. 

On June 16, 2016, AIM Photonics 

filed its original notification pursuant to 

section 6(a) of the Act. The Department 

of Justice published a notice in the 

Federal Register pursuant to section 

6(b) of the Act on July 25, 2016 (81 FR 

48450). 

The last notification was filed with 

the Department on July 1, 2024. A 

notice was published in the Federal 

Register pursuant to section 6(b) of the 

Act on September 26, 2024 (89 FR 

78903). 

Suzanne Morris, 

Deputy Director Civil Enforcement 

Operations, Antitrust Division. 

[FR Doc. 2025–02044 Filed 1–30–25; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1481] 

Bulk Manufacturer of Controlled 

Substances Application: Organic 

Consultants LLC DBA Cascade 

Chemistry 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Organic Consultants LLC DBA 

Cascade Chemistry has applied to be 

registered as a bulk manufacturer of 

basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants, therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before April 1, 2025. Such persons 

may also file a written request for a 

hearing on the application on or before 

April 1, 2025. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on November 26, 2024, 

Organic Consultants LLC DBA Cascade 

Chemistry, 90 North Polk Street, Suite 

200, Eugene, Oregon 97402–4109 

applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug code Schedule 

Amphetamine ................................................................................................................................................................... 1100 II 

Methylphenidate .............................................................................................................................................................. 1724 II 

Codeine ........................................................................................................................................................................... 9050 II 

Oxycodone ....................................................................................................................................................................... 9143 II 

Hydromorphone ............................................................................................................................................................... 9150 II 

Hydrocodone ................................................................................................................................................................... 9193 II 

Meperidine ....................................................................................................................................................................... 9230 II 

Meperidine intermediate-A .............................................................................................................................................. 9232 II 

Meperidine intermediate-B .............................................................................................................................................. 9233 II 

Meperidine intermediate-C .............................................................................................................................................. 9234 II 

Methadone ....................................................................................................................................................................... 9250 II 

Methadone intermediate .................................................................................................................................................. 9254 II 

Morphine .......................................................................................................................................................................... 9300 II 

Thebaine .......................................................................................................................................................................... 9333 II 

Oxymorphone .................................................................................................................................................................. 9652 II 

Noroxymorphone ............................................................................................................................................................. 9668 II 

Fentanyl ........................................................................................................................................................................... 9801 II 

The company plans to bulk 

manufacture small quantities of the 

listed controlled substances for internal 

use or for sale as analytical reference 

standard materials to its customers. No 

other activities for these drug codes are 

authorized for this registration. 

Matthew Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2025–02008 Filed 1–30–25; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1483] 

Importer of Controlled Substances 

Application: Medi-Physics Inc. DBA GE 

Healthcare 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Medi-Physics Inc. DBA GE 

Healthcare has applied to be registered 

as an importer of basic class(es) of 

controlled substance(s). Refer to 

SUPPLEMENTARY INFORMATION listed 

below for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants, therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before March 3, 2025. Such 


ddrumheller on DSK120RN23PROD with NOTICES1